Legal Opinion
In Re: lorazepam/cloraze v. Mylan Laboratories
District Court, District of Columbia
Decided August 18, 2017No. Misc. No. 1999-0276Published
1Opinion of the Court
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA MDL Docket No. 1290 (TFH/JMF) Misc. No. 99-276 (TFH) IN RE LORAZEPAM & CLORAZEPATE ANTITRUST LITIG. HEALTH CARE SERV. CORP., Plaintiff, v_ Civil Action No. 01-2646 (TFH) MYLAN LABS., INC., et al., Defendants. BLUE CROSS BLUE SHIELD OF MINN., BLUE CROSS BLUE SHIELD OF MASS., and FEDERATED MUT. INS. CO. Plaintiffs, Civil Action No. 02-1299 (TFH) v. MYLAN LABS., INC., et al., Defendants. ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) MEMORANDUM OPINION Following remand from the D.C. Circuit on jurisdictional grounds, the Court determined…
2Cases cited8 opinions
- Charles Carter v. District of Columbia, Maurice Turner, Chief, Metropolitan Police Department Charles Carter v. District of ColumbiaCourt of Appeals for the D.C. Circuit · 1986
- Summers v. Missouri Pacific Railroad SystemCourt of Appeals for the Tenth Circuit · 1997
- Shirley P. Langevine v. District of ColumbiaCourt of Appeals for the D.C. Circuit · 1997
- In Re Lorazepam & Clorazepate Antitrust LitigationDistrict Court, District of Columbia · 2006
- In Re Lorazepam & Clorazepate Antitrust LitigationCourt of Appeals for the D.C. Circuit · 2011
3 more not listed; retrieve them via the Exa API.